u/ButterscotchVivid867

[supprimé]

Extension 5: The Question That Was Never Binary: Alloxan, Detection, and the Study Still Owed.

In identifying the 1994 methodological flaw, I framed the UHPLC-MS/MS study as binary, either alloxan is present in human blood, or it isn’t. But the more I sat with my writing of The Alloxan Hypothesis, the more that framing feels incomplete. There is more to the question than just alloxans presence, why are we treating that question as unanswerable, when the biochemical conditions for its potential endogenous production are documented in literature?

Reactive carbonyl species are small reactive chemically active molecules generated during normal and abnormal metabolism. Methylglyoxal, glyoxal, and 3-deoxyglucosone are examples of toxic metabolic byproducts that cause dicarbonyl stress, found by researchers when using sensitive equipment. These are correlated with metabolic state. These are being discussed here because of what they show about detection. They are reactive, short lived, and for years that was treated as a reason they could not be reliable measured. Once the right instrument was used, they were found and quantified (meaning molecule present and not mistaken for another; meaning the concentration was measured, not just present).

So where would alloxan sit? The Alloxan Hypothesis proposes two theoretical routes by which it could reach human blood. The first is endogenous. Does this sequence of events run to completion in the human body, and produces alloxan at a concentration that matters?

The second is dietary. Alloxan has been detected in bleached flour in peer reviewed studies. The chemistry of industrial bleaching (oxidising agents on the grain) produces conditions under which alloxan could form, and when tested, it was found. This route to human blood depends on whether alloxan present in food survives digestion and absorption, and reaches circulation. However, the starting point (alloxan in the food) is already on record.

Suppose the proposed study is run and alloxan is found, it would be tempting to treat this as confirmation of my hypothesis. It would not be. A positive result would establish one thing: that alloxan is present in human blood at a measurable concentration. Presence is not causation. Finding alloxan in blood would not prove it destroys beta cells in the human body, or that it comes from diet, and it wouldn’t prove it contributes to type 2 diabetes and other diseases. Those are separate, each needing their own study. A positive detection makes them worth that study. Everything downstream from that, the dose, the source, the effect, becomes a line of investigation. This is what detection could bring, not an answer. A reason to keep asking.

Now suppose the opposite. The proposed study is run and alloxan is not found. This result would matter just as much. A clean negative would mean the endogenous or dietary routes I have described would not run to completion, weakening the hypothesis directly. Because alloxan is unstable, it degrades quickly in blood. A true negative requires a method built for a molecule that doesn’t wait around. If the study was designed for that and still finds nothing, the alloxan hypothesis has to give ground, and it would.

The point of this extension is simple. The 1994 question was never binary, and treating it that way is maybe what has let it sit unanswered for over thirty years. There are the two theoretical routes to alloxan in human blood, one endogenous, and one dietary. The instrument to settle it exists. I am asking for the measurement. The question is answerable. That is the whole point.

This is an extension of The Alloxan Hypothesis by Brianna Dickson

Extension 5: The Question That Was Never Binary: Alloxan, Detection, and the Study Still Owed.

In identifying the 1994 methodological flaw, I framed the UHPLC-MS/MS study as binary, either alloxan is present in human blood, or it isn’t. But the more I sat with my writing of The Alloxan Hypothesis, the more that framing feels incomplete. There is more to the question than just alloxans presence, why are we treating that question as unanswerable, when the biochemical conditions for its potential endogenous production are documented in literature?

Reactive carbonyl species are small reactive chemically active molecules generated during normal and abnormal metabolism. Methylglyoxal, glyoxal, and 3-deoxyglucosone are examples of toxic metabolic byproducts that cause dicarbonyl stress, found by researchers when using sensitive equipment. These are correlated with metabolic state. These are being discussed here because of what they show about detection. They are reactive, short lived, and for years that was treated as a reason they could not be reliable measured. Once the right instrument was used, they were found and quantified (meaning molecule present and not mistaken for another; meaning the concentration was measured, not just present).

So where would alloxan sit? The Alloxan Hypothesis proposes two theoretical routes by which it could reach human blood. The first is endogenous. Does this sequence of events run to completion in the human body, and produces alloxan at a concentration that matters?

The second is dietary. Alloxan has been detected in bleached flour in peer reviewed studies. The chemistry of industrial bleaching (oxidising agents on the grain) produces conditions under which alloxan could form, and when tested, it was found. This route to human blood depends on whether alloxan present in food survives digestion and absorption, and reaches circulation. However, the starting point (alloxan in the food) is already on record.

Suppose the proposed study is run and alloxan is found, it would be tempting to treat this as confirmation of my hypothesis. It would not be. A positive result would establish one thing: that alloxan is present in human blood at a measurable concentration. Presence is not causation. Finding alloxan in blood would not prove it destroys beta cells in the human body, or that it comes from diet, and it wouldn’t prove it contributes to type 2 diabetes and other diseases. Those are separate, each needing their own study. A positive detection makes them worth that study. Everything downstream from that, the dose, the source, the effect, becomes a line of investigation. This is what detection could bring, not an answer. A reason to keep asking.

Now suppose the opposite. The proposed study is run and alloxan is not found. This result would matter just as much. A clean negative would mean the endogenous or dietary routes I have described would not run to completion, weakening the hypothesis directly. Because alloxan is unstable, it degrades quickly in blood. A true negative requires a method built for a molecule that doesn’t wait around. If the study was designed for that and still finds nothing, the alloxan hypothesis has to give ground, and it would.

The point of this extension is simple. The 1994 question was never binary, and treating it that way is maybe what has let it sit unanswered for over thirty years. There are the two theoretical routes to alloxan in human blood, one endogenous, and one dietary. The instrument to settle it exists. I am asking for the measurement. The question is answerable. That is the whole point.

A video on YouTube, incase anyone was weary of my substack link. Just trying to eliminate any barriers for people to view or understand the hypothesis

My name is Brianna Dickson, born and raised, and writing from Northland, New Zealand. I am not a doctor, I am a student studying for my diploma in sport.

I stumbled onto this while investigating my human anatomy and physiology papers. What I found isn't a theory about "bad habits", it is a mechanistic fault in the modern industrial diet that I (Brianna Dickson) am calling, The Alloxan Hypothesis.

For over 80 years, if a scientist wanted to give a lab rat diabetes for a study, they injected it with a compound called alloxan. Alloxan is a molecular shape charge, designed with precision to destroy the insulin producing beta cells of the pancreas while leaving the cells right next to them (the alpha cells) completely untouched.

The beta cells have an evolutionary glitch, they use a doorway called GLUT2 that can't tell the difference between glucose and alloxan. Once inside, alloxan exploits the fact that beta cells have limited antioxidant defenses (1% of the catalase found in other cells). It triggers Parthanatos, named after the Greek god of death. Where the cell consumes its own energy supply trying to repair shattered DNA until it collapses.

We aren't just seeing this in labs, manufacturing this toxin in our food supply and synthesising it in our own bodies.

Exogenously: Alloxan is a direct byproduct of the industrial bleaching of flour using agents like benzoyl peroxide. It has already been detected in commercial cake flour and white bread.

Endogenously: When you consume a high fructose, high fat diet, it triggers a "panic response" that actually produces alloxan internally from uric acid through a specific chemical pathway involving xanthine oxidase and Fenton Chemistry.

This is the missing mechanism behind 537 million cases of Type 2 Diabetes globally. But the scale of this crime is much larger. This up stream pathway (chronic oxidative stress, endogenous toxin production, and inflammatory priming) has direct mechanistic connections to Cardiovascular disease,Cancer, Parkinson’s, Neurodegeneration, PCOS, Endometriosis, Adendomyosis, Infertility, and the "Connective Tissue Cluster" (Ehlers-Danlos Syndrome, MCAS, and SMAS), where structural vulnerabilities make the body even more susceptible to these toxins.

I am not claiming I have proven this to the point of clinical finality. I am claiming that the only major human study on this from 1994 had a fatal analytical flaw that confused alloxan with Vitamin B2. We have gone 30 years without a validated human study using modern mass spectrometry.

My sythensis doesn't just identify the problem, it provides a research road map for resolution.

I have done the work. I have mapped the chemistry. I am standing by this mechanistic synthesis until a modern lab using gold-standard UHPLC-MS/MS technology proves me wrong.

The full 35+ hypothesis, detailing all amplifying mechanisms, is available at

If I am right, we aren't just looking at an epidemic of "poor choices." We are looking at a global health crisis caused by an unmonitored industrial byproduct. Its about time someone asked the question.

Good morning/evening!

I am a student in 25 F in New Zealand North Island, living and feeling the cost of living sleeping in my mums garage.

During my studies, I discovered a mechanism in the human body that hasnt been addressed that I believe could be directly linked to diabetes, to then help alternative treatments commence (since stem cell treatment isnt available to everyone, and realistically wont be, with the rising epidemic). I have been down an extensive investigation into my hypothesis and have actually written out a full document and grant application. However, because I am me, and I dont have any connections in this field, I dont know where to begin, I genuinely believe I am on to something that can help people. And I want to help people!